Pitfalls in innovation policy making

Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing

Despite increasing recalls, contamination events, and shortages, drug companies continue to rely on outdated manufacturing plants and processes. Drug manufacturing’s inefficiency and lack of innovation stand in stark contrast to drug discovery, which is the focus of a calibrated innovation policy that combines patents and FDA regulation. Pharmaceutical manufacturing lags far behind the innovati...

The Study of Critical Realism Implications in Evaluation of Science, Technology and Innovation Policy Making

Objective: The purpose of this study is to identify and extract the implications of critical realism for science, technology and innovation policy-making as one of the later research traditions in social sciences. Nevertheless, its main focus, according to the different stages of the policy-making cycle and extent of its contributing factors, is on the stage of "policy evaluation". Methods: Thi...

Stakeholders\' network in Iranian health policy-making: A model for participatory policy-making

Background: Stewardship, resource generation, financing, and providing services are the 4 main functions in any health system. Using intelligence and common sense in making policies and decisions is a subcomponent of the stewardship. The present study aimed at designing a model that provides better access to the stakeholders’ wisdom.    Methods: This was a qualitative study in ...

Complementarities in innovation policy

Complementarities in Innovation Policy by Pierre Mohnen and Lars-Hendrik Röller This paper develops a framework for testing discrete complementarities in innovation policy using European data on obstacles to innovation. We propose a discrete test of supermodularity in innovation policy leading to a number of inequality constraints. We apply our test to two types of innovation decisions: to inno...

Innovation surveys and innovation policy